Customer Support Executive
About the job
- A bachelor's degree or higher is required.
- Must be flexible to work in shifts.
- Good written and verbal English communication is required.
- Proficiency with Microsoft Office, particularly Microsoft Excel and Microsoft Word, is required.
- Ability to communicate technical information in a simple manner is required.
- Respond to customers professionally to provide information about products and services, take or cancel orders, or obtain details of complaints.
- Keep records of customer interactions and transactions, recording details of inquiries, complaints, and comments, as well as actions taken; process orders, forms, and applications.
- Follow up to ensure that appropriate actions were taken on customers’ requests, aiming for First Contact Resolution.
- Refer unresolved customer grievances or special requests to designated departments for further investigation.
- Enhance the organization’s reputation by accepting ownership for accomplishing new and different requests and exploring opportunities to add value to job accomplishments.
- Customer support and other job experience is preferred.
- A collaborative mindset, customer service focus, and hands-on problem-solving ability are desired.
About the company
Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.
Company Size
1-10
Company Stage
Early VC
Total Funding
$4.2M
Headquarters
North Bethesda, Maryland
Founded
2015
Get referred to IBEX
See people who can refer or advise you
Simplify's Take
What believers are saying
- Ibex keeps an open 506(c) offering, signaling active capital formation in 2026.
- The 2022 CD147 patent supports oncology and inflammation licensing conversations.
- Anti-MIF VHH development continues, with animal-model testing already disclosed.
What critics are saying
- Ibex has no disclosed commercial products, leaving revenue dependent on financing.
- The open Regulation D offering implies dilution risk and financing pressure through 2026.
- Without clinical validation, the company risks becoming a perpetual patent shop.
What makes IBEX unique
- North Bethesda-based Ibex Biosciences focuses on antibody, gene-therapy, and stem-cell programs.
- Its 2026 pipeline spans CD147 antibodies, anti-MIF VHHs, and PCBP1 stem-cell methods.
- Ibex still controls early patentable assets, including 2022 CD147 publication.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Performance Bonus
Company News
IBEX has successfully completed a £2 million funding round to advance its mission of using X-ray technology to diagnose osteoporosis early. The company aims to shift from reactive to proactive treatment of this silent disease. With partnerships established with X-ray and mammography OEMs in 2024, IBEX plans to deploy its technology in clinical settings by 2025, demonstrating cost savings for the NHS.
Israeli light control nanotech and smart glass company Gauzy has announced that it has acquired French company Vision Systems, which develops ADAS (Advanced Driver Assistance System) and shading solutions for the aeronautic, land transport, and marine industries.